Proteomic analysis of temporally stimulated ovarian cancer cells for biomarker discovery

Molecular and Cellular Proteomics

Volumn 12, Issue 2, 2013, Pages 356-368

  Marzinke, Mark A ^a   Choi, Caitlin H ^a   Chen, Li ^a   Shih, Ie Ming ^a   Chan, Daniel W ^a   Zhang, Hui ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PROTEIN KINASE B;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER TISSUE; CELL GROWTH; CELL LABELING; CELL LYSATE; CELL PROLIFERATION; CELL STIMULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MASS SPECTROMETRY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; TISSUE MICROARRAY;

CELL LINE, TUMOR; CELL PROLIFERATION; CYSTADENOMA, SEROUS; DISEASE PROGRESSION; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; NEOPLASM GRADING; OVARIAN NEOPLASMS; PEPTIDES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84874091750     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M112.019521     Document Type: Article

References (55)

1. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., and Forman, D. (2011) Global cancer statistics. CA Cancer J. Clin. 61, 69-90
2. Jaffe, E. S., Harris, N. L., Stein, H., and Vardiman, J. W. (2001) WHO Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs, IARC Press, Lyon, France
3. Zhang, Y., Tang, H., Cai, J., Zhang, T., Guo, J., Feng, D., and Wang, Z. (2011) Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion. Cancer Lett. 303, 47-55
4. Ip, C. K., Cheung, A. N., Ngan, H. Y., and Wong, A. S. (2011) p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells. Oncogene 30, 2420-2432
5. Chakravarty, D., Roy, S. S., Babu, C. R., Dandamudi, R., Curiel, T. J., Vivas-Mejia, P., and Lopez-Berestein, G. (2011) Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis. Clin. Cancer Res. 17, 2250-2259
6. Tse, J. C., and Kalluri, R. (2007) Mechanisms of metastasis: epithelial-to- mesenchymal transition and contribution of tumor microenvironment. J. Cell. Biochem. 101, 816-829
7. Jechlinger, M., Grunert, S., and Beug, H. (2002) Mechanisms in epithelial plasticity and metastasis: insights from 3D cultures and expression profiling. J. Mammary Gland Biol. Neoplasia 7, 415-432
8. Thiery, J. P. (2002) Epithelial-mesenchymal transitions in tumour progres- sion. Nat. Rev. Cancer 2, 442-454
9. Hynes, N., and MacDonald, G. (2009) ErbB receptors and signaling path- ways in cancer. Curr. Opin. Cell. Biol. 21, 177-184
10. Stadlmann, S., Gueth, U., Reiser, U., Diener, P., Zeimet, A., Wight, E., Mirlacher, M., Sauter, G., Mihatsch, M., and Singer, G. (2006) Epithelial growth factor receptor status in primary and recurrent ovarian cancer. Mod. Pathol. 19, 607-610
11. Dimova, I., Zaharieva, B., Raitcheva, S., Dimitrov, R., Doganov, N., and Toncheva, D. (2006) Tissue microarray analysis of EGFR and erbB2 copy number changes in ovarian tumors. Int. J. Gynecol. Pathol. 16, 145-151
12. Siwak, D., Carey, M., Hennessy, B., Nguyen, C., McGahren Murray, M., Nolden, L., and Mills, G. (2010) Targeting the epidermal growth factor receptor in ovarian cancer: current knowledge and future challenges. J. Oncol. 2010, 568938
13. Brustmann, H. (2008) Epidermal growth factor receptor expression in se- rous ovarian carcinoma: an immunohistochemical study with galectin-3 and cyclin D1 and outcome. Int. J. Gynecol. Pathol. 27, 380-389
14. Psyrri, A., Kassar, M., Yu, Z., Bamias, A., Weinberger, P., Markakis, S., Kowalski, D., Camp, R., Rimm, D., and Dimopoulos, M. (2005) Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer. Clin. Cancer Res. 11, 8637-8643
15. Sheng, Q., and Liu, J. (2011) The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer. Br. J. Cancer 104, 1241-1245
16. Zhou, L., and Leung, B. S. (1992) Growth regulation of ovarian cancer cells by epidermal growth factor and transforming growth factors alpha and beta 1. Biochim. Biophys. Acta 1180, 130-136
17. Zeineldin, R., Muller, C. Y., Stack, M. S., and Hudson, L. G. (2010) Targeting the EGF receptor for ovarian cancer therapy. J. Oncol. 2010, 414676
18. Murphy, M., and Stordal, B. (2011) Erlotinib and gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review. Drug Resist. Updat. 14, 177-190
19. Posadas, E., Liel, M., Kwitkowski, V., Minasian, L., Godwin, A., Hussain, M., Espina, V., Wood, B., Steinberg, S., and Kohn, E. (2007) A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer. Cancer 109, 1323-1330
20. Gunawardana, C. G., Kuk, C., Smith, C. R., Batruch, I., Soosaipillai, A., and Diamandis, E. P. (2009) Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer. J. Proteome Res. 8, 4705-4713
21. Faca, V. M., Ventura, A. P., Fitzgibbon, M. P., Pereira-Faca, S. R., Pitteri, S. J., Green, A. E., Ireton, R. C., Zhang, Q., Wang, H., O'Briant, K. C., Drescher, C. W., Schummer, M., McIntosh, M. W., Knudsen, B. S., and Hanash, S. M. (2008) Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains. PLoS One 3(6), e2425
22. Bengtsson, S., Krogh, M., Szigyarto, C. A., Uhlen, M., Schedvins, K., Silfversward, C., Linder, S., Auer, G., Alaiya, A., and James, P. (2007) Large-scale proteomics analysis of human ovarian cancer for biomarkers. J. Proteome Res. 6, 1440-1450
23. Hamilton, T., Young, R., McKoy, W., Grotzinger, K., Green, J., Chu, E., Whang-Peng, J., Rogan, A., Green, W., and Ozols, R. (1983) Characterization of a human ovarian carcinoma cell line (NIH: OVCAR-3) with androgen and estrogen receptors. Cancer Res. 43, 5379-5389
24. Hu, L., Zaloudek, C., Mills, G. B., Gray, J., and Jaffe, R. B. (2000) In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002). Clin. Cancer Res. 6, 880-886
25. Lafky, J. M., Wilken, J. A., Baron, A. T., and Maihle, N. J. (2008) Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer. Biochim. Biophys. Acta 1785, 232-265
26. Zhang, H., Liu, A. Y., Loriaux, P., Wollscheid, B., Zhou, Y., Watts, J. D., and Aebersold, R. (2007) Mass spectrometric detection of tissue proteins in plasma. Mol. Cell. Proteomics 6, 64-71
27. Tian, Y., Tan, A. C., Sun, X., Olson, M. T., Xie, Z., Jinawath, N., Chan, D. W., Shih, I.-M., Zhang, Z., and Zhang, H. (2009) Quantitative proteomic analysis of ovarian cancer cells identified mitochondrial proteins associated with paclitaxel resistance. Proteomics Clin. Appl. 3(11), 1288-1295
28. Tian, Y., Yao, Z., Roden, R. B., and Zhang, H. (2011) Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics. Proteomics 11, 4677-4687
29. Kim, J., Coffey, D., Creighton, C., Yu, Z., Hawkins, S., and Matzuk, M. (2012) High-grade serous ovarian cancer arises from fallopian tube in a mouse model. Proc. Natl. Acad. Sci. 109, 3921-3926
30. Tone, A., Salvador, S., Finlayson, S., Tinker, A., Kwon, J., Lee, C., Cohen, T., Ehlen, T., Lee, M., Carey, M., Heywood, M., Pike, J., Hoskins, P., Stuart, G., Swenerton, K., Huntsman, D., Gilks, C., Miller, D., and McAlpine, J. (2012) The role of the fallopian tube in ovarian cancer. Clin. Adv. Hematol. Oncol. 10, 296-306
31. Han, J., Li, L., Hu, J., Yu, L., Zheng, Y., Guo, J., Zheng, X., Yi, P., and Zhou, Y. (2010) Epidermal growth factor stimulates human trophoblast cell migration through rho A and rho C activation. Endocrinology 151, 1732-1742
32. Papaiahgari, S., Yerrapureddy, A., Hassoun, P. M., Garcia, J. G., Birukov, K. G., and Reddy, S. P. (2007) EGFR-activated signaling and actin remodeling regulate cyclic stretch-induced NRF2-ARE activation. Am. J. Respir. Cell Mol. Biol. 36, 304-312
33. den Hartigh, J. C., van Bergen en Henegouwen, P. M., Verkleij, A. J., and Boonstra, J. (1992) The EGF receptor is an actin-binding protein. J. Cell Biol. 119, 349-355
34. Gagne, J. P., Ethier, C., Gagne, P., Mercier, G., Bonicalzi, M. E., Mes- Masson, A. M., Droit, A., Winstall, E., Isabelle, M., and Poirier, G. G. (2007) Comparative proteome analysis of human epithelial ovarian cancer. Proteome Sci. 24, 5-16
35. Fidler, I. J. (1990) Host and tumour factors in cancer metastasis. Eur. J. Clin. Invest. 20, 481-486
36. Sibilia, M., Kroismayr, R., Lichtenberger, B. M., Natarajan, A., Hecking, M., and Holcmann, M. (2007) The epidermal growth factor receptor: from development to tumorigenesis. Differentiation 75, 770-787
37. Vlahos, C. J., Matter, W. F., Hui, K. Y., and Brown, R. F. (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8- phenyl4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269, 5241-5248
38. Wieduwilt, M. J., and Moasser, M. M. (2008) The epidermal growth factor receptor family: biology driving targeted therapeutics. Cell. Mol. Life Sci. 65, 1566-1584
39. Mendelsohn, J., and Baselga, J. (2006) Epidermal growth factor receptor targeting in cancer. Semin. Oncol. 33, 369-385
40. Chen, J. W., Murphy, T. L., Willingham, M. C., Pastan, I., and August, J. T. (1985) Identification of two lysosomal membrane proteins. J. Cell Biol. 101, 85-95
41. Granger, B. L., Green, S. A., Gabel, C. A., Howe, C. L., Mellman, I., and Helenius, A. (1990) Characterisation and cloning of lgp110, a lysosomal membrane glycoprotein from mouse and rat cells. J. Biol. Chem. 265, 12036-12043
42. Heffernan, M., Yousefi, S., and Dennis, J. W. (1989) Molecular character- ization of P2B/LAMP-1, a major protein target of a metastasis-associated oligosaccharide structure. Cancer Res. 49, 6077-6084
43. Kannan, K., Stewart, R. M., Bounds, W., Carlsson, S. R., Fukuda, M., Betzing, K. W., and Holcombe, R. F. (1996) Lysosome-associated membrane proteins h-LAMP1 (CD107a) and h-LAMP2 (CD107b) are activation-dependent cell surface glycoproteins in human peripheral blood mononuclear cells which mediate cell adhesion to vascular endothelium. Cell. Immunol. 171, 10-19
44. Silverstein, R. L., and Febbraio, M. (1992) Identification of lysosome-asso- ciated membrane protein-2 as an activation-dependent platelet surface glycoprotein. Blood 80, 1470-1475
45. Holcombe, R. F., Baethge, B. A., Stewart, R. M., Betzing, K., Hall, V. C., Fukuda, M., and Wolf, R. E. (1993) Cell surface expression of lysosomeassociated membrane proteins (LAMPs) in scleroderma: relationship of LAMP2 to disease duration, anti-Sc170 antibodies, serum interleukin-8, and soluble interleukin-2 receptor levels. Clin. Immunol. Immunopathol. 67, 31-39
46. Williams, M. A., and Fukuda, M. (1990) Accumulation of membrane glyco- proteins in lysosomes requires a tyrosine residue at a particular position in the cytoplasmic tail. J. Cell Biol. 111, 955-966
47. Dahlgren, C., Carlsson, S. R., Karlsson, A., Lundqvist, H., and Sjolin, C. (1995) The lysosomal membrane glycoproteins LAMP-1 and LAMP-2 are present in mobilizable organelles, but are absent from the azurophil granules of human neutrophils. Biochem. J. 311, 667-674
48. Peters, P. J., Borst, J., Oorschot, V., Fukuda, M., Krahenbuhl, O., Tschopp, J., Slot, J. W., and Geuze, H. J. (1991) Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J. Exp. Med. 173, 1099-1109
49. Krishnan, V., Bane, S. M., Kawle, P. D., Naresh, K. N., Kalraiya, R. D. (2005) Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium. Clin. Exp. Metastasis 22, 11-24
50. Inohara, H., and Raz, A. (1994) Identification of human melanoma cellular and secreted ligands for galectin-3. Biochem. Biophys. Res. Commun. 201, 1366-1375
51. Kunzli, B. M., Berberat, P. O., Zhu, Z. W., Martignoni, M., Kleeff, J., Tempia-Caliera, A. A., Fukuda, M., Zimmermann, A., Friess, H., and Buchler, M. W. (2002) Influences of the lysosomal associated membrane proteins (LAMP-1, LAMP-2) and MAC-2 binding protein (MAC-2-BP) on the prognosis of pancreatic carcinoma. Cancer 94, 228-239
52. Spano, J. R., Fagard, R., Soria, J.-C., Rixe, O., Khayat, D., and Milano, G. (2005) Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives. Ann. Oncol. 16, 189-194
53. Seiden, M. V., Burris, H. A., Matulonis, U., Hall, J. B., Armstrong, D. K., Speyer, J., Weber, J. D. A., and Muggia, F. (2007) A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignancies. Gynecol. Oncol. 104, 727-731
54. Meunier, L., Puiffe, M. L., Le Page, C., Filali-Mouhim, A., Chevrette, M., Tonin, P. N., Provencher, D. M., and Mes-Masson, A. (2010) Effect of ovarian cancer ascites on cell migration and gene expression in an epithelial ovarian cancer in vitro model. Transl. Oncol. 3, 230-238
55. Chen, X., and Wang, Z. (2001) Regulation of intracellular trafficking of the EGF receptor by Rab5 in the absence of phosphatidylinositol 3-kinase activity. EMBO Rep. 2, 68-74